Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Zinzino AB announces acquisition of Sanki to enhance wellness presence throughout Americas Zinzino AB to acquire Sanki for USD 8 million to expand wellness distribution across the Americas. Discover what this means for its global test-based health strategy. byVenkateshNovember 10, 2025